Ann Pharm Fr. 2013 Jul;71(4):203-15. doi: 10.1016/j.pharma.2013.05.002. Epub 2013 Jun 17.
Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
Sarbach C, Stevens P, Whiting J, Puget P, Humbert M, Cohen-Kaminsky S, Postaire E.
Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
Sarbach C, Stevens P, Whiting J, Puget P, Humbert M, Cohen-Kaminsky S, Postaire E.
N Engl J Med. 2013 Jul 25;369(4):351-61. doi: 10.1056/NEJMoa1211097.
A novel channelopathy in pulmonary arterial hypertension.
Ma L, Roman-Campos D, Austin ED, Eyries M, Sampson KS, Soubrier F, Germain M, Trégouët DA, Borczuk A, Rosenzweig EB, Girerd B, Montani D, Humbert M, Loyd JE, Kass RS, Chung WK.
A novel channelopathy in pulmonary arterial hypertension.
Ma L, Roman-Campos D, Austin ED, Eyries M, Sampson KS, Soubrier F, Germain M, Trégouët DA, Borczuk A, Rosenzweig EB, Girerd B, Montani D, Humbert M, Loyd JE, Kass RS, Chung WK.
Circulation. 2013 Jul 30;128(5):512-23. doi: 10.1161/CIRCULATIONAHA.113.001585. Epub 2013 Jun 26.
Therapeutic Efficacy of AAV1.SERCA2a in Monocrotaline-Induced Pulmonary Arterial Hypertension.
Hadri L, Kratlian RG, Benard L, Maron BA, Dorfmüller P, Ladage D, Guignabert C, Ishikawa K, Aguero J, Ibanez B, Turnbull IC, Kohlbrenner E, Liang L, Zsebo K, Humbert M, Hulot JS, Kawase Y, Hajjar RJ, Leopold JA.
Therapeutic Efficacy of AAV1.SERCA2a in Monocrotaline-Induced Pulmonary Arterial Hypertension.
Hadri L, Kratlian RG, Benard L, Maron BA, Dorfmüller P, Ladage D, Guignabert C, Ishikawa K, Aguero J, Ibanez B, Turnbull IC, Kohlbrenner E, Liang L, Zsebo K, Humbert M, Hulot JS, Kawase Y, Hajjar RJ, Leopold JA.
Am J Respir Crit Care Med. 2013 Aug 1;188(3):402-4. doi: 10.1164/rccm.201301-0010LE.
Pulmonary alveolar proteinosis revealing a telomerase disease.
Marchand-Adam S, Diot B, Magro P, De Muret A, Guignabert C, Kannengiesser C, Londono-Vallejo A, Draskovic I, Toutain A, Diot P.
Pulmonary alveolar proteinosis revealing a telomerase disease.
Marchand-Adam S, Diot B, Magro P, De Muret A, Guignabert C, Kannengiesser C, Londono-Vallejo A, Draskovic I, Toutain A, Diot P.
Int J Cancer. 2013 Aug 3. doi: 10.1002/ijc.28413. [Epub ahead of print]
Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
Belmont L, Rabbe N, Antoine M, Cathelin D, Guignabert C, Kurie J, Cadranel J, Wislez M.
Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
Belmont L, Rabbe N, Antoine M, Cathelin D, Guignabert C, Kurie J, Cadranel J, Wislez M.
Presse Med. 2013 Sep;42(9 Pt 2):e334-41. doi: 10.1016/j.lpm.2013.07.003. Epub 2013 Aug 29.
Autologous tracheal replacement: From research to clinical practice.
Fabre D, Kolb F, Fadel E, Leymarie N, Mussot S, Le Chevalier T, Dartevelle P.
Autologous tracheal replacement: From research to clinical practice.
Fabre D, Kolb F, Fadel E, Leymarie N, Mussot S, Le Chevalier T, Dartevelle P.
Semin Respir Crit Care Med. 2013 Oct;34(5):689-99. doi: 10.1055/s-0033-1355444. Epub 2013 Sep 13.
Experimental models of right heart failure: a window for translational research in pulmonary hypertension.
Guihaire J, Bogaard HJ, Flécher E, Noly PE, Mercier O, Haddad F, Fadel E.
Experimental models of right heart failure: a window for translational research in pulmonary hypertension.
Guihaire J, Bogaard HJ, Flécher E, Noly PE, Mercier O, Haddad F, Fadel E.
Semin Respir Crit Care Med. 2013 Oct;34(5):714-24. doi: 10.1055/s-0033-1356494. Epub 2013 Sep 13.
Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword?
Godinas L, Guignabert C, Seferian A, Perros F, Bergot E, Sibille Y, Humbert M, Montani D.
Tyrosine kinase inhibitors in pulmonary arterial hypertension: a double-edge sword?
Godinas L, Guignabert C, Seferian A, Perros F, Bergot E, Sibille Y, Humbert M, Montani D.
Semin Respir Crit Care Med. 2013 Oct;34(5):551-9. doi: 10.1055/s-0033-1356496. Epub 2013 Sep 13.
Pathology and pathobiology of pulmonary hypertension.
Guignabert C, Dorfmuller P.
Pathology and pathobiology of pulmonary hypertension.
Guignabert C, Dorfmuller P.
Am J Respir Crit Care Med. 2013 Sep 15;188(6):756-9. doi: 10.1164/rccm.201303-0467LE.
A Proof of Concept for the Detection and Classification of Pulmonary Arterial Hypertension through Breath Analysis with a Sensor Array.
Cohen-Kaminsky S, Nakhleh M, Perros F, Montani D, Girerd B, Garcia G, Simonneau G, Haick H, Humbert M.
A Proof of Concept for the Detection and Classification of Pulmonary Arterial Hypertension through Breath Analysis with a Sensor Array.
Cohen-Kaminsky S, Nakhleh M, Perros F, Montani D, Girerd B, Garcia G, Simonneau G, Haick H, Humbert M.